retatrutide approval for Weight Loss: TRIUMPH-1 Results, Cost, Insurance Retatrutide for weight loss: Study

GLP-1 receptor agonists are not appropriate in certain situations, including: Personal or family history of medullary thyroid carcinoma (MTC) History of multiple endocrine neoplasia syndrome type 2 (MEN2) Pregnancy or breastfeeding Known hypersensitivity to the medication History of pancreatitis (relative contraindication

In just 15 days, participants often see meaningful improvements in weight, cholesterol, blood pressure, blood sugar, energy, and sleep

Lancet 406 (10522), 29272944

Eiros R, Romero-Gonzlez G, Gavira JJ, Beloqui O, Colina I, Fortn Landecho M, Lpez B, Gonzlez A, Dez J, Ravassa S (2020) Does chronic kidney disease facilitate malignant myocardial fibrosis in heart failure with preserved ejection fraction of hypertensive origin

(Lausanne) 8, 630962